SA. Well, this is very exciting because again, we're bringing drug prices down to … Tremendous cuts. … 6, 700%. A little bit more than that. So today I'm thrilled to announce that the two world's largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP1 weight loss drug. (20:46–20:48)
CLAIM
Asserts that there are significant reductions or cuts, likely in a policy or budget context.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
